The innate immune response to infection represents the first cellular defense against invading pathogens. This response is orchestrated by a complex cohort of genes that are specifically induced upon infection and include cytokines, chemokines as well as other important antiviral mediators. While the function of many of these infectioninduced genes (and their antiviral activity) remains elusive, their regulated expression establishes an 'antiviral state' in the cell that is essential for the host defense to infections. Despite their protective role in infection, prolonged or aberrant expression of such genes can be deleterious to the host. As such, the expression of many antiviral mediators is strictly regulated, with subsets of genes expressed in distinct temporal patterns during infection. We plan here to characterize the function and mechanism of action of the putative helicase SETX, which is mutated in human patients with ataxia with oculomotor apraxia (AOA2) and a subset of Lou Gehrig's disease (ALS4). Our preliminary data using patientsderived SETX deficient cells indicate that SETX is a major player in controlling the antiviral response.
We aim at understanding through a multiscale analysis involving integrative proteomic and genomic approach the mechanism regulating SETX activity during infection.

Public Health Relevance

Despite their protective role in infection, prolonged or aberrant expression of antiviral genes can be deleterious to the host. As such, the expression of many antiviral mediators is then strictly regulated, with subsets of genes expressed in distinct temporal patterns during infection. We used reporterbased assays coupled with chemical inhibitors of chromatin regulators to reveal a role for the helicase SETX in controlling the induction of antiviral genes. Using cuttingedge multiscale analysis we will study SETX regulation during infection, its mechanism of action, and the role during infection of SETX alleles that predispose to congenital defects like AOA2 and ALS4.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI114770-01A1
Application #
9104372
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Palker, Thomas J
Project Start
2015-08-01
Project End
2016-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Rialdi, Alexander; Hultquist, Judd; Jimenez-Morales, David et al. (2017) The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity. Cell 169:679-692.e14
Rialdi, Alex; Campisi, Laura; Zhao, Nan et al. (2016) Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science 352:aad7993
Heaton, Nicholas S; Moshkina, Natasha; Fenouil, Romain et al. (2016) Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. Immunity 44:46-58